Active, Not Recruiting
Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma
NCT01843374
- Conditions
- Adenoma, Diabetes Mellitus, Insulin-Dependent, 12, Lung Diseases, +13 more
- Locations
-
- Research Site Scottsdale, Arizona, United States
- Research Site La Jolla, California, United States
- Research Site Los Angeles, California, United States
- Research Site San Francisco, California, United States